Introduction

Achieving CE marking under EU MDR is one of the most important milestones for medical device manufacturers entering the European market.

But for many companies—especially startups and first-time manufacturers—the process can feel overwhelming.

The challenge is not just preparing documents.

It is understanding how different regulatory elements connect:

• Device classification
• Clinical evaluation
• Risk management
• Technical documentation
• PMS and PMCF requirements

Under MDR, CE marking is no longer a simple checklist exercise.

It is a structured demonstration that your device is:

• Safe
• Effective
• Supported by evidence
• Compliant with regulatory requirements

This article breaks down the CE marking process step by step.

1. Understand Whether Your Product Is a Medical Device

The first step is determining whether your product qualifies as a medical device under MDR.

This depends on:

• Intended purpose
• Claims made by the manufacturer
• Mode of action

Products intended for:

• Diagnosis
• Prevention
• Monitoring
• Treatment
• Alleviation of disease or injury

may fall under MDR.

This stage is critical because incorrect qualification can affect the entire regulatory pathway.

2. Determine Device Classification

Once the product qualifies as a medical device, the next step is classification.

Under EU MDR, devices are generally classified as:

• Class I
• Class IIa
• Class IIb
• Class III

Classification depends on factors such as:

• Duration of contact
• Invasiveness
• Intended use
• Risk level

Why classification matters:

• It determines documentation requirements
• It affects clinical evidence expectations
• It defines whether a Notified Body is required

Incorrect classification is one of the most common regulatory mistakes.

3. Identify Applicable General Safety and Performance Requirements (GSPRs)

Manufacturers must demonstrate compliance with MDR’s General Safety and Performance Requirements (GSPRs).

These cover areas such as:

• Risk management
• Biological safety
• Clinical performance
• Labeling and IFU requirements
• Chemical and physical properties

A GSPR checklist or matrix is commonly used to demonstrate conformity.

This step forms the foundation of technical documentation.

4. Implement a Quality Management System (QMS)

A Quality Management System is essential for MDR compliance.

Most manufacturers align their systems with ISO 13485.

The QMS typically covers:

• Design controls
• Supplier management
• Complaint handling
• CAPA
• Document control
• Post-market activities

Under MDR, quality management is closely linked to regulatory compliance.

A weak QMS can delay CE marking significantly.

5. Conduct Risk Management

Manufacturers must establish a structured risk management process aligned with ISO 14971.

Risk management includes:

• Hazard identification
• Risk estimation
• Risk control measures
• Residual risk evaluation
• Benefit-risk analysis

Under MDR, risk management is not a one-time activity.

It must remain connected to:

• Clinical evaluation
• PMS
• PMCF
• Biological evaluation

6. Perform Biological Evaluation

For devices with patient contact, biological safety assessment is critical.

Biological evaluation is generally performed according to ISO 10993.

This may involve:

• Material characterization
• Toxicological assessment
• Biological testing (if required)
• Scientific justification for omitted testing

Manufacturers often underestimate the importance of:

• Material information
• Supplier documentation
• Processing impacts

Weak biological justification is a common cause of regulatory findings.

7. Prepare Clinical Evaluation

Clinical evaluation is one of the most important parts of MDR compliance.

The Clinical Evaluation Report (CER) demonstrates:

• Safety
• Clinical performance
• Benefit-risk acceptability

Clinical evidence may include:

• Literature data
• Clinical investigations
• Post-market data
• Equivalence justification (where applicable)

Under MDR, clinical evaluation requirements are significantly stricter than under previous directives.

8. Prepare Technical Documentation

Technical documentation is the core evidence package supporting CE marking.

It generally includes:

• Device description
• Intended use
• Design information
• Risk management documentation
• Biological evaluation
• Clinical evaluation
• Verification and validation data
• Labeling and IFU
• PMS documentation

Under MDR, documentation must be:

• Consistent
• Traceable
• Scientifically justified

9. Establish PMS and PMCF Plans

Post-Market Surveillance (PMS) is now a major regulatory focus under MDR.

Manufacturers must establish systems for:

• Complaint handling
• Trend analysis
• Vigilance
• Periodic review of device performance

For many devices, a Post-Market Clinical Follow-up (PMCF) plan is also expected.

PMS and PMCF are not just post-market obligations.

They are part of the overall evidence strategy.

10. Determine Whether a Notified Body Is Required

For most devices above Class I, manufacturers must work with a Notified Body.

The Notified Body reviews:

• Technical documentation
• QMS compliance
• Clinical evidence
• Regulatory alignment

Under MDR, Notified Body scrutiny has increased significantly.

Manufacturers should prepare for:

• Detailed questions
• Clarification requests
• Longer review timelines

11. Undergo Conformity Assessment

The conformity assessment process evaluates whether the device meets MDR requirements.

This may involve:

• Documentation review
• QMS audits
• Clinical evidence assessment
• Sampling of technical files

Successful completion results in:

• MDR certification (if applicable)
• Authorization to affix the CE mark

12. Affix the CE Mark and Register the Device

Once conformity assessment is completed:

• The CE mark can be affixed
• Devices can be placed on the EU market

Manufacturers may also need:

• EUDAMED registration
• UDI implementation
• Economic operator registration

13. Maintain Compliance After CE Marking

CE marking is not the end of the process.

Under EU MDR, compliance is continuous.

Manufacturers must maintain:

• PMS activities
• Vigilance reporting
• PMCF activities
• Technical documentation updates
• Risk management reviews

Regulatory compliance is now a lifecycle responsibility.

Common Mistakes Manufacturers Make

Some of the most common MDR issues include:

• Incorrect device classification
• Weak clinical evidence
• Poor documentation alignment
• Incomplete PMS planning
• Generic justifications
• Lack of traceability between documents

Many delays occur not because requirements are impossible—but because planning starts too late.

Final Thought

The CE marking process under EU MDR is far more rigorous than previous European frameworks.

But successful compliance is achievable with:

• Early regulatory strategy
• Strong documentation
• Cross-functional coordination
• Evidence-based justification

Because ultimately, CE marking is not just about obtaining approval.

It is about demonstrating that your device is consistently safe, effective, and supported throughout its lifecycle.